CAS: 1629229-37-3 - [(8R)-5,6-Dihydro-8-methyl-3-(3-methyl-1,2,4-thiadiazol-5-yl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl](4-fluorophenyl)methanone

Fórmula: C₁₆H₁₅FN₆OS

InChI: InChI=1S/C16H15FN6OS/c1-9-13-19-20-14(15-18-10(2)21-25-15)23(13)8-7-22(9)16(24)11-3-5-12(17)6-4-11/h3-6,9H,7-8H2,1-2H3/t9-/m1/s1

Clave InChI: InChIKey=PPSNFPASKFYPMN-SECBINFHSA-N

SMILES: O=C(C1=CC=C(F)C=C1)N2CCN3C(=NN=C3C2C)C4=NC(=NS4)C

Fezolinetant

CAS: 1629229-37-3

Fezolinetant (ESN-364) is a neurokinin-3 receptor antagonist that is being investigated for menopausal hot flashes.Cost-effective …

• Fórmula: C₁₆H₁₅FN₆OS
• Pureza: 98.62% - 99.70%
• Forma y color: Solid
• Peso molecular: 358.39

Fezolinetant

CAS: 1629229-37-3

• Fórmula: C₁₆H₁₅FN₆OS
• Pureza: 98%
• Forma y color: Solid
• Peso molecular: 358.3933

Fezolinetant

CAS: 1629229-37-3

• Fórmula: C₁₆H₁₅FN₆OS
• Peso molecular: 358.40

Fezolinetant-d4

CAS: 1629229-37-3

• Fórmula: C₁₆H₁₁D₄FN₆OS
• Peso molecular: 362.42

Fezolinetant

CAS: 1629229-37-3

Fezolinetant is a drug for the treatment of menopausal symptoms. It is designed to be …

• Fórmula: C₁₆H₁₅FN₆OS
• Pureza: Min. 95%
• Peso molecular: 358.39 g/mol